NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Clinical trials for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for controlling debilitating spinal arthritis
Disease control CompletedThis study tested a drug called secukinumab in Chinese adults with active non-radiographic axial spondyloarthritis, a type of inflammatory arthritis that mainly affects the spine and causes significant back pain and stiffness. For the first 16 weeks, some participants received th…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC
-
Two-Year Check-Up: how well does a common biologic drug work in everyday life?
Disease control CompletedThis study followed 127 adults for two years to see how well they stayed on a prescribed drug called secukinumab, which treats several related inflammatory conditions. Researchers tracked whether patients continued treatment and measured changes in their symptoms, pain, and quali…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC